Application segmentation defines the end‑use contexts in which Broadbean Peptone is deployed, directly shaping market valuation. In cell culture media, peptones supply essential nitrogen sources, supporting mammalian cell growth for biopharma pipelines; this segment accounts for roughly 40 % of total revenue due to its high‑volume demand in monoclonal antibody production. Microbial fermentation utilizes peptones as complex nutrients for bacteria and fungi, driving a 35 % share as industrial biotech firms scale up enzyme and metabolite synthesis. The recombinant protein expression niche, primarily involving insect and yeast platforms, contributes 15 %, reflecting specialized formulation requirements that command premium pricing. Finally, vaccine production leverages peptones for viral seed‑stock amplification, representing 10 % of the market. These application categories collectively constitute the Broadbean Peptone segmentation framework, allowing analysts to allocate resources, forecast growth, and assess risk across distinct production ecosystems.